ParaPRO announced that the Food and Drug Administration (FDA) has approved an expanded age range for Natroba (spinosad) Topical Suspension, to include children ≥6 months of age who have pediculosis capitis (head lice).
Natroba, a pediculicide derived from soil microbe, was initially approved in 2011 for use in patients ≥4 years of age. The active ingredient causes neuronal excitation in insects. After periods of hyperexcitation, lice become paralyzed and die.
RELATED: Lice and Scabies Treatments
Natroba Topical Suspension is available as a 0.9% strength in 4oz bottles.
Continue Reading
For more information call (855) 628-4622 or visit Natroba.com.
